Beximco Pharmaceuticals PLC. (DSE:BXPHARMA)
148.00
-0.10 (-0.07%)
At close: Jul 26, 2026
DSE:BXPHARMA Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, DSE:BXPHARMA stock has a consensus rating of "Strong Buy" and an average price target of ৳145.75. The average 1-year stock price forecast is 1.52% lower than the current stock price, while the lowest is ৳138.50 (-6.42%) and the highest is ৳153.00 (+3.38%).
Price Target: ৳145.75 (-1.52%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for DSE:BXPHARMA stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Jul '25 | Oct '25 | Feb '26 | Mar '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 3 | 2 | 2 | 1 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 3 | 2 | 2 | 1 | 2 |
Financial Forecast
Revenue This Year
54.69B
from 49.12B
Increased by 11.33%
Revenue Next Year
60.64B
from 54.69B
Increased by 10.88%
EPS This Year
15.50
from 15.56
Decreased by -0.39%
EPS Next Year
20.50
from 15.50
Increased by 32.26%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is BDT.